Vancouver biotech Zymeworks buying Theravance for US$929M

时代殖民者报，Times Colonist，加拿大不列颠哥伦比亚省维多利亚市的日报。关注

Transaction helps Zymeworks diversify and shift toward respiratory-disease treatments in addition to those for cancers

添加评论
点赞收藏
点踩分享查看原文
评论
?
参与讨论